Behaviour change versus nutritional intelligence.
Noom is a weight-loss program built around weekly lessons and human coaches. SNAQ is an AI nutritionist built around your glucose response. Different problems, different tools.
In short.
Noom is a behavioural weight-loss platform built around CBT-style daily lessons, colour-coded calorie tracking and human coaching, now bundled with GLP-1 telehealth prescriptions. SNAQ is an AI nutritionist for diabetes, prediabetes and GLP-1 users, with photo carb counting, predictive glucose response, and an RCT in eClinicalMedicine. Noom solves behaviour change; SNAQ solves nutritional decisions at every meal.
At a glance.
- Noom's evidence base is strong on behavioural outcomes (40+ peer-reviewed papers on methodology).
- Noom has no glucose model. SNAQ overlays CGM data and predicts the response before you eat.
- Noom's GLP-1 program is medication-led; SNAQ's GLP-1 guidance is nutrition-led, focused on protein intake and muscle preservation.
- Noom uses a colour-coded food classification system. SNAQ shows your individual glucose impact, which is personalised by definition.
- Both have large US user bases; SNAQ is also global.
Feature by feature.
Structured comparison based on publicly available information, last reviewed May 2026.
| Feature | SNAQ | Noom |
|---|---|---|
| Primary goal | Diabetes, prediabetes, GLP-1, metabolic outcomes | Weight loss via behaviour change |
| Meal logging | Photo AI, 5.5 g mean absolute carb error | Manual entry + colour-category classification |
| Glucose prediction and CGM integration | ✅ 20+ devices, predictive | ❌ |
| Coaching style | AI Nutritionist, always on | Human coach + CBT-style daily lessons |
| GLP-1 program design | Nutrition-led, protein + muscle preservation | Medication-led with general nutrition lessons |
| Peer-reviewed clinical evidence (product-specific) | ✅ RCT 2025, eClinicalMedicine (TIR) | ✅ Behavioural outcomes (HbA1c, weight) |
| Pricing | From $2.66/mo (3-year plan), 7-day free trial | $17.42–$70/mo weight; $69–$149+/mo with GLP-1 |
| Best for | People whose decisions are glucose-driven, including GLP-1 users | Behavioural weight loss with weekly check-ins and lessons |
Sources: Herzig D. et al., JMIR mHealth and uHealth, 2020 (carb counting accuracy) Piazza et al., eClinicalMedicine 2025 (RCT NCT05671679, Time-in-Range) SNAQ research overview Noom pricing blog
Why users switch.
Nutritional intelligence at every meal
Noom's daily lesson teaches a concept. SNAQ's AI Nutritionist coaches you at the moment of decision, based on your own glucose data.
Built around the cohort
If you have diabetes or take a GLP-1, you need protein guidance and glucose response, not colour categories.
RCT on Time in Range
Noom's evidence base is on behavioural outcomes. SNAQ's RCT measured Time in Range, the metric that matters in diabetes.
Honest take.
Choose SNAQ if…
- Diabetes, prediabetes or a GLP-1 medication is part of your reality.
- You want glucose-aware guidance, not generic behaviour lessons.
- You want a low-friction way to try, and the option to bring your own sensor.
Consider Noom if…
- Weight loss is your only goal and you respond well to lessons and human coaches.
- You want a single program that bundles GLP-1 prescription with the app.
Bottom line
Noom is the right tool for behavioural weight loss. SNAQ is the right tool for understanding and improving glucose response. Diabetes and GLP-1 goals belong with SNAQ.
Published randomised controlled trial evidence, measured against standard care in T1D patients on automated insulin delivery systems.
Source: eClinicalMedicine (The Lancet), 2025 · Piazza et al. · NCT05671679
Frequently asked.
What's the main difference between SNAQ and Noom?
Is the clinical evidence for SNAQ independently verified?
Which CGMs and devices does SNAQ work with?
Does SNAQ prescribe GLP-1 medications?
Is SNAQ a weight-loss app?
See the difference yourself.
No logbook can coach you. Download SNAQ free and find out what your data has been trying to tell you.
4.6 · 3,000+ App Store ratings